The Report of the Results of HPV Oligonucleotide Microarray Tested on the First Voided Urine of Patients of CIN and Cervix Cancer.
- Author:
Eun Seop SONG
1
;
Sun Hwan KOH
;
Yun Seob SONG
;
Se Ryun KIM
;
Sung Ook HWANG
;
Jee Hyun PARK
;
Seung Kwon KOH
;
Moon Whan IM
;
Byoung Ick LEE
;
Woo Young LEE
Author Information
1. Department of Obstetrics and Gynecology, College of Medicine, Inha University, Incheon, Korea.
- Publication Type:Original Article
- Keywords:
CIN;
Cervix cancer;
Urine;
Cervix;
HPV oligonucleotide microarray
- MeSH:
Adenocarcinoma;
Biopsy;
Cervix Uteri*;
DNA;
Female;
Human papillomavirus 16;
Humans;
Neoplasms, Squamous Cell;
Oligonucleotide Array Sequence Analysis*;
Uterine Cervical Neoplasms*
- From:Korean Journal of Obstetrics and Gynecology
2003;46(11):2139-2145
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: To know whether HPV Oligonucleotide Microarray (HPVDNAChip) can detect the HPV DNA in the urine and, if it can, to compare the results with Pap smear, biopsy, and cervix HPVDNAChip. METHODS: The authors had done Pap smear, cervix HPVDNAChip and colposcopy-guided punch biopsy as well as detailed information to those who visited Dept. of Ob. And Gyn. during 1st of April to 31st of May in 2003 for their uterine cervical problems related to the neoplasia. When they were determined to admit for treatment, urine had been collected to be tested by HPVDNAChip. RESULTS: Among 25 patients enrolled in this study, there were 10 whose urine HPVDNAChip test turned out positive (40%). Among 10 positive results, 9 patients had HPV 16 subtypes. Among 10 urine HPVDNAChip positive patients, there were 5 HSIL, 4 squamous cell cancer (SCC), and 1 ASCUS cell types on the Pap smears. Among 15 urine HPVDNAChip negative patients, there were 7 HSIL, 5 SCC, 1 ASCUS, 1 LSIL, and 1 AGUS. Among 10 urine HPVDNAChip there are 5 CIN3, and 4 invasive SCC, and 1 adenocarcinoma at the biopsy. Among 15 urine HPVDNAChip negative patients, there are 7 CIN3, 6 invasive SCC, 1 adenocarcinoma in situ, and 1 CIN1 patient. Whenever there were a urine HPVDNAChip 16 subtype positive, there were always cervix HPVDNAChip 16 subtype positive, but among the 12 urine HPVDNAChip negative patients, 5 had HPV 16 subtype positive and 4 had another subtypes and 3 had negative on cervix HPVDNAChip tests. CONCLUSION: Using HPVDNAChip, we verified that 40% of patients had the HPV DNA in their urine who had admitted for the treatment of their cervical neoplasm. And HPV 16 subtype was the most common type in the urine. If we can extend this data more widely, we might use it as an auxiliary tool for cervical HPV infection.
